Bartlett & Co’s Globus Medical GMED Stock Holding History

Bartlett & Co’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-28	Closed	-$2K	–	1098
2020 Q4	$2K	Buy	+28	New	+$1.61K	﹤0.01%	913

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Bartlett & Co's GMED Position: Q1 2021 in Review

Bartlett & Co sold out of Globus Medical (GMED) in Q1 2021, closing a stake of 28 shares — an estimated $2K sold.

Bartlett & Co first reported a position in GMED in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 345 funds tracked by Wall St. Rank hold GMED as of Q1 2021.

Bartlett & Co reported no remaining Globus Medical position as of Q1 2021 after selling out during the quarter.
Bartlett & Co sold 28 Globus Medical shares in Q1 2021, an estimated $2K.
Bartlett & Co first reported a position in Globus Medical in Q4 2020 and held it in 1 quarter.
Bartlett & Co's Globus Medical position peaked at $2K in Q4 2020.
345 funds tracked by Wall St. Rank held Globus Medical as of Q1 2021.

Based on Bartlett & Co's 13F filing for Q1 2021, filed 19 Apr 2021.